Unknown

Dataset Information

0

Apatinib as an alternative therapy for advanced hepatocellular carcinoma.


ABSTRACT: Angiogenesis plays an important role in the occurrence and development of tumors. Registered tyrosine kinase inhibitors targeting vascular endothelial growth factor reduce angiogenesis. Apatinib, a tyrosine kinase inhibitor, can specifically inhibit vascular endothelial growth factor receptor 2, showing encouraging anti-tumor effects in a variety of tumors including advanced hepatocellular carcinoma (HCC). This article intends to review the clinical research and application prospects of apatinib in the field of HCC.

SUBMITTER: Zhang XH 

PROVIDER: S-EPMC7643208 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Apatinib as an alternative therapy for advanced hepatocellular carcinoma.

Zhang Xi-Hao XH   Cao Man-Qing MQ   Li Xiu-Xiu XX   Zhang Ti T  

World journal of hepatology 20201001 10


Angiogenesis plays an important role in the occurrence and development of tumors. Registered tyrosine kinase inhibitors targeting vascular endothelial growth factor reduce angiogenesis. Apatinib, a tyrosine kinase inhibitor, can specifically inhibit vascular endothelial growth factor receptor 2, showing encouraging anti-tumor effects in a variety of tumors including advanced hepatocellular carcinoma (HCC). This article intends to review the clinical research and application prospects of apatinib  ...[more]

Similar Datasets

| S-EPMC5739662 | biostudies-literature
| S-EPMC7475472 | biostudies-literature
| S-EPMC7732574 | biostudies-literature
| S-EPMC10121316 | biostudies-literature
| S-EPMC9152289 | biostudies-literature
| S-EPMC7576000 | biostudies-literature
| S-EPMC10090460 | biostudies-literature
| S-EPMC10487462 | biostudies-literature
| S-EPMC4970483 | biostudies-literature
| S-EPMC9006370 | biostudies-literature